BRAF mutation in the elderly submitted to thyroidectomy (Q45789710)

16 December 2017

title

BRAF mutation in the elderly submitted to thyroidectomy (English)

1 reference

16 December 2017

author name string

Antonio Augusto T Bertelli

1

1 reference

16 December 2017

Antonio José Gonçalves

2

1 reference

16 December 2017

Marcelo B Menezes

3

1 reference

16 December 2017

Murilo R Melo

4

1 reference

16 December 2017

Stefano Tincani

5

1 reference

16 December 2017

Luiz Cláudio Bosco Massarollo

6

1 reference

16 December 2017

publication date

1 March 2013

1 reference

16 December 2017

Revista do Colégio Brasileiro de Cirurgiões

published in

1 reference

16 December 2017

volume

40

1 reference

16 December 2017

issue

2

1 reference

16 December 2017

page(s)

110-116

1 reference

16 December 2017

How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

BRAF mutation in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

BRAF mutations in an Italian cohort of thyroid cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

RKIP and BRAF aberrations in human nasal polyps and the adjacent turbinate mucosae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

Clinical prognosis in BRAF-mutated PTC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

The prevalence and prognostic value of BRAF mutation in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

Seven-year follow-up of a juvenile female with papillary thyroid carcinoma with poor outcome, BRAF mutation and loss of expression of iodine-metabolizing genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

Is BRAF the Achilles' Heel of Thyroid Cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-69912013000200005

10.1590/S0100-69912013000200005

21 January 2018

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017